TNF and inflammatory bowel disease: A recent case series suggested that combining vedolizumab with TNF inhibitor therapy in patients with IBD is a promising treatment option in those experiencing loss of response to TNF inhibitors.125,126 This is further supported by an analysis of data from patients with refractory CD showing that patients experienced clinical, biomarker and endoscopic improvements following concomitant treatment with two biologics.127